Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents | Next Article »
Circulation. 2007;115:114-126
Published online before print December 27, 2006, doi: 10.1161/CIRCULATIONAHA.106.179294
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
115/1/114    most recent
CIRCULATIONAHA.106.179294v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buse, J. B.
Right arrow Articles by Stone, N. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buse, J. B.
Right arrow Articles by Stone, N. J.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Diabetes Complications
Related Collections
Right arrow Nutrition
Right arrow Lipids
Right arrow Primary prevention
Right arrow Exercise testing
Right arrow Risk Factors
Right arrow Other hypertension
Right arrow Type 1 diabetes
Right arrow Type 2 diabetes
Right arrow Other diabetes
Right arrow Glucose intolerance
Right arrow AHA Statements and Guidelines
Right arrow Exercise/exercise testing/rehabilitation

(Circulation. 2007;115:114-126.)
© 2007 American Heart Association, Inc.

AHA/ADA Scientific Statement

Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus

A Scientific Statement From the American Heart Association and the American Diabetes Association

John B. Buse, MD, PhD, Co-chair; Henry N. Ginsberg, MD, FAHA, Co-chair; George L. Bakris, MD, FAHA; Nathaniel G. Clark, MD, MS, RD; Fernando Costa, MD, FAHA; Robert Eckel, MD, FAHA; Vivian Fonseca, MD; Hertzel C. Gerstein, MD, MSc, FRCPC; Scott Grundy, MD, FAHA; Richard W. Nesto, MD, FAHA; Michael P. Pignone, MD, MPH; Jorge Plutzky, MD; Daniel Porte, MD; Rita Redberg, MD, FAHA; Kimberly F. Stitzel, MS, RD; Neil J. Stone, MD, FAHA

The American Heart Association (AHA) and the American Diabetes Association (ADA) have each published guidelines for cardiovascular disease prevention: The ADA has issued separate recommendations for each of the cardiovascular risk factors in patients with diabetes, and the AHA has shaped primary and secondary guidelines that extend to patients with diabetes. This statement will attempt to harmonize the recommendations of both organizations where possible but will recognize areas in which AHA and ADA recommendations differ.


Key Words: AHA Scientific Statement • cardiovascular diseases • diabetes mellitus • primary prevention




This article has been cited by other articles:


Home page
 Cleveland Clinic Journal of MedicineHome page
W. T. CEFALU, R. J. RICHARDS, and L. Y. MELENDEZ-RAMIREZ
Redefining treatment success in type 2 diabetes mellitus: Comprehensive targeting of core defects
Cleveland Clinic Journal of Medicine, December 1, 2009; 76(Suppl_5): S39 - S47.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
G. De Berardis, M. Sacco, G. F M Strippoli, F. Pellegrini, G. Graziano, G. Tognoni, and A. Nicolucci
Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials
BMJ, November 6, 2009; 339(nov06_1): b4531 - b4531.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. G. Bertoni and D. W. Kitzman
Coronary Artery Calcium: A Clue to the Enigma of Tight Glycemic Control and Cardiovascular Disease?
Diabetes, November 1, 2009; 58(11): 2448 - 2449.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
P. M. Nilsson
Hypertension and Diabetes: Should We Treat Early Surrogates?: What are the cons?
Diabetes Care, November 1, 2009; 32(suppl_2): S290 - S293.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
Y. Kamari, R. Bitzur, H. Cohen, A. Shaish, and D. Harats
Should All Diabetic Patients Be Treated With a Statin?
Diabetes Care, November 1, 2009; 32(suppl_2): S378 - S383.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
R. F. Redberg, E. J. Benjamin, V. Bittner, L. T. Braun, D. C. Goff Jr, S. Havas, D. R. Labarthe, M. C. Limacher, D. M. Lloyd-Jones, S. Mora, et al.
ACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease) developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association Endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research.
J. Am. Coll. Cardiol., September 29, 2009; 54(14): 1364 - 1405.
[Full Text] [PDF]

Home page
 CirculationHome page
WRITING COMMITTEE MEMBERS, R. F. Redberg, E. J. Benjamin, V. Bittner, L. T. Braun, D. C. Goff Jr, S. Havas, D. R. Labarthe, M. C. Limacher, D. M. Lloyd-Jones, et al.
ACCF/AHA 2009 Performance Measures for Primary Prevention of Cardiovascular Disease in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease): Developed in Collaboration With the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: Endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research
Circulation, September 29, 2009; 120(13): 1296 - 1336.
[Full Text] [PDF]

Home page
 Circ Cardiovasc Qual OutcomesHome page
S. J. Lewis, K. M. Fox, M. F. Bullano, S. Grandy, and for the SHIELD Study Group
Knowledge of Heart Disease Risk Among SHIELD Respondents With Dyslipidemia
Circ Cardiovasc Qual Outcomes, May 1, 2009; 2(3): 207 - 212.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes and Vascular Disease ResearchHome page
S. Tavintharan, Ning Cheung, Su Chi Lim, W. Tay, A. Shankar, E. Shyong Tai, and T. Y. Wong
Prevalence and risk factors for peripheral artery disease in an Asian population with diabetes mellitus
Diabetes and Vascular Disease Research, April 1, 2009; 6(2): 80 - 86.
[Abstract] [PDF]

Home page
 ANN INTERN MEDHome page
U.S. Preventive Services Task Force
Aspirin for the Prevention of Cardiovascular Disease: U.S. Preventive Services Task Force Recommendation Statement
Ann Intern Med, March 17, 2009; 150(6): 396 - 404.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
CORONARY REVASCULARIZATION WRITING GROUP, M. R. Patel, G. J. Dehmer, J. W. Hirshfeld, P. K. Smith, and J. A. Spertus
ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: A Report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology: Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography
Circulation, March 10, 2009; 119(9): 1330 - 1352.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. R. Patel, G. J. Dehmer, J. W. Hirshfeld, P. K. Smith, and J. A. Spertus
ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: A Report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography
J. Am. Coll. Cardiol., February 10, 2009; 53(6): 530 - 553.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
J. S. Skyler, R. Bergenstal, R. O. Bonow, J. Buse, P. Deedwania, E. A.M. Gale, B. V. Howard, M. S. Kirkman, M. Kosiborod, P. Reaven, et al.
Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A Position Statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association
J. Am. Coll. Cardiol., January 20, 2009; 53(3): 298 - 304.
[Full Text] [PDF]

Home page
 CirculationHome page
J. S. Skyler, R. Bergenstal, R. O. Bonow, J. Buse, P. Deedwania, E. A.M. Gale, B. V. Howard, M. S. Kirkman, M. Kosiborod, P. Reaven, et al.
Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A Position Statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association
Circulation, January 20, 2009; 119(2): 351 - 357.
[Full Text] [PDF]

Home page
 HeartHome page
S. Singh and C. D Furberg
Thiazolidinediones and cardiovascular outcomes in type 2 diabetes
Heart, January 1, 2009; 95(1): 1 - 3.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
J. S. Skyler, R. Bergenstal, R. O. Bonow, J. Buse, P. Deedwania, E. A.M. Gale, B. V. Howard, M. S. Kirkman, M. Kosiborod, P. Reaven, et al.
Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association
Diabetes Care, January 1, 2009; 32(1): 187 - 192.
[Full Text] [PDF]

Home page
 Diabetes and Vascular Disease ResearchHome page
J.-C. Fruchart, F. M Sacks, M. P Hermans, G. Assmann, W V. Brown, R. Ceska, M J. Chapman, P. M Dodson, P. Fioretto, H. N Ginsberg, et al.
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients
Diabetes and Vascular Disease Research, November 1, 2008; 5(4): 319 - 335.
[Abstract] [PDF]

Home page
 Am J Health Syst PharmHome page
J. Odom, B. Williamson, and L. Carter
Rosiglitazone and pioglitazone in the treatment of diabetes mellitus
Am. J. Health Syst. Pharm., October 1, 2008; 65(19): 1846 - 1850.
[Full Text] [PDF]

Home page
 Arch Intern MedHome page
J. M. Jakicic, B. H. Marcus, W. Lang, and C. Janney
Effect of Exercise on 24-Month Weight Loss Maintenance in Overweight Women
Arch Intern Med, July 28, 2008; 168(14): 1550 - 1559.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes Spectr.Home page
J. L. Boucher and D. G. Hurrell
Cardiovascular Disease and Diabetes
Diabetes Spectr, July 1, 2008; 21(3): 154 - 155.
[Full Text] [PDF]

Home page
 Diabetes Spectr.Home page
R. F. Pereira and M. J. Franz
Prevention and Treatment of Cardiovascular Disease in People With Diabetes Through Lifestyle Modification: Current Evidence-Based Recommendations
Diabetes Spectr, July 1, 2008; 21(3): 189 - 193.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
U. Campia and J. A. Panza
Flavanol-rich cocoa a promising new dietary intervention to reduce cardiovascular risk in type 2 diabetes?
J. Am. Coll. Cardiol., June 3, 2008; 51(22): 2150 - 2152.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
A. Y. Gasparyan, T. Watson, and G. Y.H. Lip
The Role of Aspirin in Cardiovascular Prevention: Implications of Aspirin Resistance
J. Am. Coll. Cardiol., May 13, 2008; 51(19): 1829 - 1843.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
T. K. Schramm, G. H. Gislason, L. Kober, S. Rasmussen, J. N. Rasmussen, S. Z. Abildstrom, M. L. Hansen, F. Folke, P. Buch, M. Madsen, et al.
Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk: A Population Study of 3.3 Million People
Circulation, April 15, 2008; 117(15): 1945 - 1954.
[Abstract] [Full Text] [PDF]

Home page
 QJMHome page
A. Elis, L. Rosenmann, G. Chodick, A.D. Heymann, E. kokia, and V. Shalev
The association between glycemic, lipids and blood pressure control among Israeli diabetic patients
QJM, April 1, 2008; 101(4): 275 - 280.
[Abstract] [Full Text] [PDF]

Home page
 Mayo Clin Proc.Home page
R. B. Goldberg and T. A. Jacobson
Effects of Niacin on Glucose Control in Patients With Dyslipidemia
Mayo Clin. Proc., April 1, 2008; 83(4): 470 - 478.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
S. E. Inzucchi and D. K. McGuire
New Drugs for the Treatment of Diabetes: Part II: Incretin-Based Therapy and Beyond
Circulation, January 29, 2008; 117(4): 574 - 584.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
D. K. McGuire and S. E. Inzucchi
New Drugs for the Treatment of Diabetes Mellitus: Part I: Thiazolidinediones and Their Evolving Cardiovascular Implications
Circulation, January 22, 2008; 117(3): 440 - 449.
[Full Text] [PDF]

Home page
 J Am Coll Cardiol ImgHome page
T. Amano, T. Matsubara, T. Uetani, M. Nanki, N. Marui, M. Kato, T. Yoshida, K. Arai, K. Yokoi, H. Ando, et al.
Abnormal glucose regulation is associated with lipid-rich coronary plaque: relationship to insulin resistance.
J. Am. Coll. Cardiol. Img., January 1, 2008; 1(1): 39 - 45.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
J. J. Bax, L. H. Young, R. L. Frye, R. O. Bonow, H. O. Steinberg, and E. J. Barrett
Screening for Coronary Artery Disease in Patients With Diabetes
Diabetes Care, October 1, 2007; 30(10): 2729 - 2736.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes and Vascular Disease ResearchHome page
A. Zambon and K. Cusi
The role of fenofibrate in clinical practice
Diabetes and Vascular Disease Research, September 1, 2007; 4(3_suppl): S15 - S20.
[Abstract] [PDF]

Home page
 JAMAHome page
S. M. Donahoe, G. C. Stewart, C. H. McCabe, S. Mohanavelu, S. A. Murphy, C. P. Cannon, and E. M. Antman
Diabetes and Mortality Following Acute Coronary Syndromes
JAMA, August 15, 2007; 298(7): 765 - 775.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
J. Lewis
Treating Diabetic Nephropathy: Unfinished Success Is Not Failure
Clin. J. Am. Soc. Nephrol., May 1, 2007; 2(3): 407 - 409.
[Full Text] [PDF]


Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.